HANSA BIOPHARMA LIMITED - GODALMING
| Company Profile | Company Filings |
Overview
HANSA BIOPHARMA LIMITED is a Private Limited Company from GODALMING UNITED KINGDOM and has the status: Active.
HANSA BIOPHARMA LIMITED was incorporated 11 years ago on 15/01/2013 and has the registered number: 08361712. The accounts status is SMALL and accounts are next due on 30/09/2024.
HANSA BIOPHARMA LIMITED was incorporated 11 years ago on 15/01/2013 and has the registered number: 08361712. The accounts status is SMALL and accounts are next due on 30/09/2024.
HANSA BIOPHARMA LIMITED - GODALMING
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
ASHCOMBE COURT
GODALMING
SURREY
GU7 1LQ
UNITED KINGDOM
This Company Originates in : United Kingdom
Previous trading names include:
IMMAGO BIOSYSTEMS LIMITED (until 08/02/2019)
IMMAGO BIOSYSTEMS LIMITED (until 08/02/2019)
OXFORD ANTIBODIES LIMITED (until 09/10/2013)
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 15/01/2024 | 29/01/2025 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| FERDINAND GREGOR WINTER | Nov 1981 | German | Director | 2023-08-30 | CURRENT |
| CHRISTINA SOFIE SJÖSTRÖM | Apr 1977 | Swedish | Director | 2024-02-28 | CURRENT |
| DR CHRISTOPHER NEIL SCANLAN | Aug 1977 | British | Director | 2013-01-15 UNTIL 2013-05-05 | RESIGNED |
| MR CHARLES DENIS SCANLAN | Dec 1944 | British | Director | 2014-03-11 UNTIL 2016-07-19 | RESIGNED |
| MR PETER LAING | Aug 1956 | British | Director | 2013-02-15 UNTIL 2013-08-21 | RESIGNED |
| MS EVA-MARIA VIKTORIA JOED | Apr 1969 | Swedish | Director | 2018-01-10 UNTIL 2020-02-05 | RESIGNED |
| DR RAYMOND JOHN CRISPIN | Nov 1949 | British | Director | 2013-01-15 UNTIL 2016-07-19 | RESIGNED |
| DR MATTHEW DAVID MAX CRISPIN | Nov 1978 | British | Director | 2013-01-15 UNTIL 2016-07-19 | RESIGNED |
| MR EMANUEL FREDRIK BJORNE | Jul 1973 | Swedish | Director | 2018-01-10 UNTIL 2020-02-05 | RESIGNED |
| MR NILS G??RAN ARVIDSSON | Mar 1960 | Swedish | Director | 2016-07-19 UNTIL 2017-11-07 | RESIGNED |
| DONATO SPOTA | Aug 1971 | Italian | Director | 2020-02-05 UNTIL 2024-02-28 | RESIGNED |
| LUDVIK KARL TOMASSON | Jan 1966 | Icelandic | Director | 2020-02-05 UNTIL 2023-08-31 | RESIGNED |
Persons with Significant Control
| Name | Active from | Born | Address | Level of control |
|---|---|---|---|---|
| Hansa Biopharma Ab | 2016-07-19 | Lund Se-220-07 |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent |
|
| Dr Matthew David Max Crispin | 2016-04-06 - 2016-07-19 | 11/1978 | Cheltenham Gloucestershire |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Free Reports Available
| Report | Date Filed | Date of Report | Assets |
|---|---|---|---|
| HANSA_BIOPHARMA_LIMITED - Accounts | 2023-12-07 | 31-12-2022 | £21,777 Cash £108,254 equity |
| Immago Biosystems Limited - Accounts to registrar (filleted) - small 17.3 | 2018-01-27 | 31-12-2016 | £36 Cash £-7,073 equity |
| Immago Biosystems Limited - Abbreviated accounts 16.1 | 2016-10-28 | 31-01-2016 | £99 Cash £-1,947 equity |
| Abbreviated Company Accounts - IMMAGO BIOSYSTEMS LIMITED | 2015-08-22 | 31-01-2015 | £580 Cash £9,966 equity |